Pharmaceuticals

Slidejuj.JPG

Gene-to-Patient Market Size, Share & Trends Analysis Report By Type (Gene Therapy, Gene Editing, Gene Silencing), By Application (Cancer Treatment, Genetic Disorders, Cardiovascular Diseases, Rare Diseases, Infectious Diseases), By End-user (Hospitals, Research Institutes, Biopharmaceutical Companies, Diagnostic Laboratories), By Technology, By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

The Gene-to-Patient Market Size is valued at USD 134.6 billion in 2023 and is predicted to reach USD 341.4 billion by the year 2031 at a 12.5% CAGR during the forecast period for 2024-2031. The gene-to-patient method intends to diagnose, treat, or...

View Sample PDF

Slideij1.JPG

Oxycodone Hydrochloride Market Size, Share & Trends Analysis Report By Type (Controlled-Release, Immediate-Release), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And By Segment Forecasts, 2024-2031

The Oxycodone Hydrochloride Market Size is valued at USD 412.4 Mn in 2023 and is predicted to reach USD 572.8 Mn by the year 2031 at a 4.33% CAGR during the forecast period for 2024-2031. Oxycodone hydrochloride is a prescribed opioid analgesic ut...

View Sample PDF

Digital_Psychotherapeutics_Market.JPG

Digital Psychotherapeutics Market Size, Share & Trends Analysis Report, By Type (Mobile Apps, Online Platforms, Virtual Reality, Wearable Devices), By Indication (Phobias and Anxiety Disorders, Psychotic Disorders), By Business Model, By Application, By End User, By Region, Forecasts, 2024-2031

The Global Digital Psychotherapeutics Market Size is valued at USD 1.27 billion in 2023 and is predicted to reach USD 8.47 billion by the year 2031 at a 26.90% CAGR during the forecast period for 2024-2031.   The use of digital techn...

View Sample PDF

slld10.JPG

Coronavirus Vaccine Market Size, Share & Trends Analysis Report By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV), Vaccine Type (Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, S-Protein based coronavirus vaccine), Region, And Segment Forecasts, 2023-2031.

The Coronavirus Vaccine Market is expected to grow at a -12.0 % CAGR during the forecast period for 2024-2034. Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and c...

View Sample PDF

Slidoij.JPG

Radiolabeling Services Market Size, Share & Trends Analysis Distribution by Product Type (C-14, H-3, I-125), Application (Pharmacokinetics and Pharmacodynamics, Medical) By Region, And By Segment Forecasts, 2024-2031

The Radiolabeling Services Market Size is predicted to exhibit an 18.6% CAGR during the forecast period for 2024-2031.   The market for radiolabeling services plays a critical role in fulfilling the needs of scientific research into pharmaceut...

View Sample PDF

Slide2ok.JPG

Medical Physics Market Share & Trends Analysis Report, By Modality (Diagnostics (Radiographic X-Ray Systems, Fluoroscopic X-Ray Systems, Dental X-Ray Systems, Mammography Systems, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, SPECT, PET, Others), Therapeutics (LINAC, Brachytherapy)), By Service, By End User, By Region, and Segment Forecasts, 2024-2031

The Medical Physics Market Size is valued at USD 5.16 Bn in 2023 and is predicted to reach USD 8.11 Bn by the year 2031 at an 5.9% CAGR during the forecast period for 2024-2031. Medical physics is a field that applies physics principles and method...

View Sample PDF

poki.JPG

Alopecia Market Size, Share & Trends Analysis Report Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Androgenetic Alopecia, Alopecia Totalis, Alopecia Universalis), By Treatment (Pharmaceutical, Devices), By Gender (Male, Female), By Sales Channel (Prescriptions, OTC), By End-use, By Region, And By Segment Forecasts, 2024-2031

The Alopecia Market Size is valued at USD 8.6 billion in 2023 and is predicted to reach USD 17.8 billion by the year 2031 at a 9.8% CAGR during the forecast period for 2024-2031. Alopecia is an autoimmune disease that damages hair follicles and ca...

View Sample PDF

Slideok21.JPG

Autosomal Dominant Hypocalcemia Type 1 Market Size, Share & Trends Analysis Report By Treatment (Calcium Analogs, Vitamin Analogs), By End-User (Hospitals, Clinics, Others), By Region, And By Segment Forecasts, 2024-2031

The Autosomal Dominant Hypocalcemia Type 1 Market Size is predicted to grow at a 2.96% CAGR during the forecast period for 2024-2031. Autosomal dominant hypocalcemia type 1 (ADH1) is a rare inherited condition characterized by abnormally low blood...

View Sample PDF

Slide2ws1.JPG

Diabetic Macular Edema Market Size, Share & Trends Analysis Report By Drug Type (Anti-VEGF (Ranibizumab (Lucentis), Aflibercept (Eylea)), Corticosteroid Therapies (Dexamethasone (Ozurdex), Fluocinolone Acetonide (Iluvien)), Others), By Form (Intravitreal Injections, Intravitreal Implants), By Distribution Channel, By Region, And By Segment Forecasts, 2024-2031

The Diabetic Macular Edema Market Size is valued at USD 3.95 billion in 2023 and is predicted to reach USD 4.56 billion by the year 2031 at a 1.9% CAGR during the forecast period for 2024-2031. Diabetic Macular Edema (DME) is an ocular disorder as...

View Sample PDF

Slideh.JPG

Cytokine Release Syndrome Management Market Size, Share & Trends Analysis Report By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type, By Route of Administration, By End User, By Region, And By Segment Forecasts, 2024-2031

The Cytokine Release Syndrome Management Market Size is valued at USD 23.1 billion in 2023 and is predicted to reach USD 36.8 billion by the year 2031 at a 6.2% CAGR during the forecast period for 2024-2031. Management of Cytokine Release Syndrome...

View Sample PDF

Categories